Nakamura Toshio, Kakinuma Hiroyuki, Amada Hideaki, Miyata Noriyuki, Taniguchi Kazuo, Koda Ayumi, Sato Masakazu
Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd, 403 Yoshino-Cho 1-Chome, Kita-ku, Saitama-Shi, Saitama 331-9530, Japan.
Bioorg Med Chem. 2004 Dec 1;12(23):6209-19. doi: 10.1016/j.bmc.2004.08.047.
Improvement of the physical properties of pyrazole derivative 1, which we reported previously as a potent and selective 20-HETE synthase inhibitor (IC(50) 5.7 nM), is described. Introduction of a sufficient substituted-amino group on the side chain enhanced the water-solubility of 1 (0.014 mg/mL at pH 6.8). Among the products, 2-piperazinoethoxy derivatives 3e and 6b showed solubility suitable for injection and potent inhibitory activity toward 20-HETE synthase (IC(50) 21.2 and 14.0 nM, respectively).
我们之前报道的作为一种强效且选择性的20-HETE合酶抑制剂(IC(50) 5.7 nM)的吡唑衍生物1的物理性质得到了改善。在侧链上引入足够的取代氨基增强了1的水溶性(在pH 6.8时为0.014 mg/mL)。在这些产物中,2-哌嗪基乙氧基衍生物3e和6b表现出适合注射的溶解度以及对20-HETE合酶的强效抑制活性(IC(50)分别为21.2和14.0 nM)。